Inflammation & Allergy - Drug Targets (Discontinued)
Title:Acknowledgements to the Reviewers
Volume: 12 Issue: 6
Export Options
About this article
Cite this article as:
Acknowledgements to the Reviewers, Inflammation & Allergy - Drug Targets (Discontinued) 2013; 12 (6) . https://dx.doi.org/10.2174/187152811206131217113450
DOI https://dx.doi.org/10.2174/187152811206131217113450 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Journals
Related Books
9
Related Articles
-
Macrophage-Derived IL-18 Targeting for the Treatment of Crohns Disease
Current Drug Targets - Inflammation & Allergy Specific Targeting of Engineered Nanoparticles to Activated Macrophages
Current Nanoscience Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Current Medicinal Chemistry Innate Immunity and Microbes: Conversations with the Gut Leading to Intestinal Tissue Repair and Fibrosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Current Molecular Medicine Acknowledgements to Contributors
Recent Patents on Inflammation & Allergy Drug Discovery Molecular Adjuvants Based on Plasmids Encoding Protein Aggregation Domains Affect Bone Marrow Niche Homeostasis
Current Gene Therapy Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands
Mini-Reviews in Medicinal Chemistry Inflammatory and Oxidative Stress Markers as Indicator of Atherogenesis in Rats: Antioxidants as Preventive Pharmacological Methods
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases
Current Pharmaceutical Design Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity
Letters in Drug Design & Discovery Commentary
CNS & Neurological Disorders - Drug Targets The Role of Phospholipase A2 and Lipoxygenases Associated with Arachidonic Acid in Oxidative Stress-Induced Cell Injury
Current Enzyme Inhibition Gene Therapy in Systemic Lupus Erythematosus
Current Gene Therapy Global Vision about the Biological Medicinal Products: Biosimilars (April, 2009)
Current Pharmaceutical Biotechnology Inhibition of Type 1 Diabetes Development by Vitamin D Receptor Agonists
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Partial QSAR Analysis of Some Selected Natural Inhibitors of FAAH Suggests a Working Hypothesis for the Development of Endocannabinoid- Based Drugs
Current Drug Targets - CNS & Neurological Disorders Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients
Current Vascular Pharmacology Cnidarian Neurotoxic Peptides Affecting Central Nervous System Targets
Central Nervous System Agents in Medicinal Chemistry Supertargeted Chemistry: Identifying Relationships Between Molecular Structures and their Sub-Cellular Distribution
Current Topics in Medicinal Chemistry